Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes

Geert Leroux‐Roels, Sylvain Fleury, Frédéric Clément et al.|PLoS ONE|2013

Cited by 77